Microsoft Word - 150511_Cancellation of Treasury Share_Eg.docx Astellas Announces Cancellation of Treasury Shares

Tokyo, Japan, May 11, 2015 - Astellas Pharma Inc. (Tokyo: 4503; President and CEO: Yoshihiko Hatanaka, hereinafter called "the Company") announced that at the meeting of the Board of Directors held today, a resolution was adopted that the Company will cancel its treasury shares, pursuant to Article 178 of the Japanese Corporate Law.
Particulars
1. Class of shares to be cancelled Common stock of the Company
2. Number of shares to be cancelled 38 million shares
(Representing 1.68% of issued shares prior to cancellation)
3. Cancellation date May 29, 2015
(Reference)
1. Following cancellation, the Company will have 2,221,823,175 issued shares.
2. Total number of the Company's treasury shares after cancellation will be 28,681,660. (Expected numbers of shares described above 1 and 2 were calculated on the basis of the issued
shares and the Company's treasury shares as of March 31, 2015, respectively.)

#######

Contacts for inquiries or additional information

Astellas Pharma Inc. Corporate Communications

Tel: +81-3-3244-3201 Fax: +81-3-5201-7473 http://www.astellas.com/en

distributed by